ArticleHemaSphere2026

Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study.

Chan Y Cheah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.